TEAS RF New Application

DOJOLVI

Ultragenyx Pharmaceutical Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88352451
Filing Date: 03/22/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88352451
MARK INFORMATION
*MARK DOJOLVI
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT DOJOLVI
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Ultragenyx Pharmaceutical Inc.
*STREET 60 Leveroni Court
*CITY Novato
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94949
EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FOAD)
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Anne H. Peck
ATTORNEY DOCKET NUMBER 315613-20000
FIRM NAME Cooley LLP
STREET 1299 Pennsylvania Avenue NW, Suite 700
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20004
EMAIL ADDRESS trademarks@cooley.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Salsabil Ahmed, Vincent J. Badolato, Susan Piascik Christoff, John W. Crittenden, Janet L. Cullum, Brian Focarino, Bobby A. Ghajar, Colette A. Ghazarian, Rebecca Givner-Forbes, Shannan Higgins, Ariana G. Hiscott, Brendan J. Hughes, Rose Mendenhall Kautz, Mary Klumpp, Judd D. Lauter, Lori A. Levine, John Paul Oleksiuk, Marcus D. Peterson, Elisa Rosen, Shane Rumbaugh, Peter J. Willsey, and Karen K. Won
CORRESPONDENCE INFORMATION
NAME Anne H. Peck
FIRM NAME Cooley LLP
STREET 1299 Pennsylvania Avenue NW, Suite 700
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20004
*EMAIL ADDRESS trademarks@cooley.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Thomas Kassberg/
SIGNATORY'S NAME Thomas Kassberg
SIGNATORY'S POSITION Chief Business Officer and Executive Vice President
SIGNATORY'S PHONE NUMBER 5105416937
DATE SIGNED 03/21/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88352451
Filing Date: 03/22/2019

To the Commissioner for Trademarks:

MARK: DOJOLVI (Standard Characters, see mark)
The literal element of the mark consists of DOJOLVI.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Ultragenyx Pharmaceutical Inc., a corporation of Delaware, having an address of
      60 Leveroni Court
      Novato, California 94949
      United States
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FOAD)
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Anne H. Peck and Salsabil Ahmed, Vincent J. Badolato, Susan Piascik Christoff, John W. Crittenden, Janet L. Cullum, Brian Focarino, Bobby A. Ghajar, Colette A. Ghazarian, Rebecca Givner-Forbes, Shannan Higgins, Ariana G. Hiscott, Brendan J. Hughes, Rose Mendenhall Kautz, Mary Klumpp, Judd D. Lauter, Lori A. Levine, John Paul Oleksiuk, Marcus D. Peterson, Elisa Rosen, Shane Rumbaugh, Peter J. Willsey, and Karen K. Won of Cooley LLP      1299 Pennsylvania Avenue NW, Suite 700
      Washington, District of Columbia 20004
      United States
      trademarks@cooley.com (authorized)
The attorney docket/reference number is 315613-20000.
The applicant's current Correspondence Information:
      Anne H. Peck
      Cooley LLP
      1299 Pennsylvania Avenue NW, Suite 700
      Washington, District of Columbia 20004
      trademarks@cooley.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Thomas Kassberg/   Date: 03/21/2019
Signatory's Name: Thomas Kassberg
Signatory's Position: Chief Business Officer and Executive Vice President
Payment Sale Number: 88352451
Payment Accounting Date: 03/25/2019

Serial Number: 88352451
Internet Transmission Date: Fri Mar 22 15:32:31 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201903221532314
19280-88352451-6202dae9da38ac66fcb2aa165
bbc36d5cd9483bdf1e75dbcc1204857d8f5abcf5
b-DA-1870-20190318165648885537

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed